| Pharmaceutical Information |
| Drug Name |
Histamine |
| Drug ID |
BADD_D01071 |
| Description |
A depressor amine derived by enzymatic decarboxylation of histidine. It is a powerful stimulant of gastric secretion, a constrictor of bronchial smooth muscle, a vasodilator, and also a centrally acting neurotransmitter. |
| Indications and Usage |
Histamine phosphate is indicated as a diagnostic aid for the evaluation of gastric acid secretory function. |
| Marketing Status |
approved; investigational |
| ATC Code |
L03AX14 |
| DrugBank ID |
DB05381
|
| KEGG ID |
D08040
|
| MeSH ID |
D006632
|
| PubChem ID |
774
|
| TTD Drug ID |
D04USC
|
| NDC Product Code |
65044-9998; 63083-1522; 81701-111 |
| UNII |
820484N8I3
|
| Synonyms |
Histamine | Peremin | Histamine Dihydrochloride | Histamine Hydrochloride | Ceplene |
|
| Chemical Information |
| Molecular Formula |
C5H9N3 |
| CAS Registry Number |
51-45-6 |
| SMILES |
C1=C(NC=N1)CCN |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
|
|
|
